- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 209/12 - Radicaux substitués par des atomes d'oxygène
Détention brevets de la classe C07D 209/12
Brevets de cette classe: 622
Historique des publications depuis 10 ans
|
45
|
48
|
63
|
28
|
37
|
28
|
50
|
34
|
25
|
24
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| FUJIFILM Corporation | 30514 |
17 |
| Sensorium Therapeutics, Inc. | 42 |
16 |
| Achillion Pharmaceuticals, Inc. | 157 |
14 |
| Janssen Pharmaceuticals, Inc. | 435 |
11 |
| BioCryst Pharmaceuticals, Inc. | 181 |
11 |
| Vertex Pharmaceuticals Incorporated | 1582 |
10 |
| Katholieke Universiteit Leuven | 1283 |
10 |
| The Johns Hopkins University | 5882 |
9 |
| Kanna Health Ltd. | 14 |
9 |
| Bristol-myers Squibb Company | 4742 |
8 |
| California Institute of Technology | 4040 |
8 |
| Novartis AG | 10262 |
6 |
| The Regents of the University of California | 20745 |
6 |
| Versicolor Technologies, LLC | 10 |
6 |
| BASF SE | 21303 |
5 |
| Wyeth LLC | 607 |
5 |
| Merck Patent GmbH | 5728 |
5 |
| The Board of Trustees of the University of Illinois | 2751 |
5 |
| Toyama Chemical Co., Ltd. | 88 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
5 |
| Autres propriétaires | 451 |